These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
66 related items for PubMed ID: 9042229
1. Effects of verapamil and S9788 on MDR-1 mRNA expression studied by in situ hybridization. Joly P, Lallemand A, Oum'Hamed Z, Trentesaux C, Idoine O, Desplaces A. Anticancer Res; 1996; 16(6B):3609-14. PubMed ID: 9042229 [Abstract] [Full Text] [Related]
2. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry. Sebille S, Morjani H, Poullain MG, Manfait M. Anticancer Res; 1994; 14(6A):2389-93. PubMed ID: 7825978 [Abstract] [Full Text] [Related]
3. [In vitro characterization of S9788, a new modulator of multidrug resistance]. Pérez V, Pierré A, Léonce S, Anstett M, Prost JF, Atassi G. Bull Cancer; 1993 Apr; 80(4):310-25. PubMed ID: 8173185 [Abstract] [Full Text] [Related]
4. Effect of duration of exposure to S9788, cyclosporin A or verapamil on sensitivity of multidrug resistant cells to vincristine or doxorubicin. Pérez V, Pierré A, Léonce S, Anstett M, Atassi G. Anticancer Res; 1993 Apr; 13(4):985-90. PubMed ID: 8352569 [Abstract] [Full Text] [Related]
5. Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells. Merlin JL, Marchal S, Ramacci C, Dieterlen A, Schultz G, Lucas C, Poullain MG, Berlion M. Cytometry; 1995 Aug 01; 20(4):315-23. PubMed ID: 7587719 [Abstract] [Full Text] [Related]
6. [Pharmacological properties of S9788, a new modulator of multidrug resistance]. Bull Cancer; 1994 Feb 01; 81(2):93-103. PubMed ID: 7894124 [Abstract] [Full Text] [Related]
7. [Effect of quinine on the multiple drug resistance and intracellular distribution of pirarubicin in LR73 tumor cells: a comparative study with verapamil and S9788 by confocal laser microspectrofluorometry]. Belhoussine R, Morjani H, Manfait M. Bull Cancer; 1997 Apr 01; 84(4):343-9. PubMed ID: 9238156 [Abstract] [Full Text] [Related]
8. [Difference between the effects of S9788, verapamil and quinine on the reversion of multidrug resistance in two human tumor cell lines]. Bennis S, Robert J. Bull Cancer; 1994 Oct 01; 81(10):886-90. PubMed ID: 7734772 [No Abstract] [Full Text] [Related]
9. Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro. Hill BT, van der Graaf WT, Hosking LK, de Vries EG, Mulder NH, Whelan RD. Int J Cancer; 1993 Sep 09; 55(2):330-7. PubMed ID: 8103761 [Abstract] [Full Text] [Related]
10. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity. Sulová Z, Macejová D, Seres M, Sedlák J, Brtko J, Breier A. Toxicol In Vitro; 2008 Feb 09; 22(1):96-105. PubMed ID: 17920233 [Abstract] [Full Text] [Related]
11. [Effect of the modality of exposure on the action of S9788 on the modulation of multidrug resistance of human tumor cell lines]. Merlin JL, Marchal S, Ramacci C, Lucas C, Paraire M, Poullain MG. Bull Cancer; 1994 Oct 09; 81(10):906-9. PubMed ID: 7734778 [No Abstract] [Full Text] [Related]
12. [Quantitative cytological study of the activity of a new resistance modulator, S 9788, on human leukemic cells using multiparametric image analysis]. Oum'Hamed Z, Berlion M, Millot-Broglio C, Dufer J, Joly P, Bizzari JP, Desplaces A. Bull Cancer; 1994 Mar 09; 81(3):203-11. PubMed ID: 7894128 [Abstract] [Full Text] [Related]
13. Effects of MDR reversing agent combinations on the 3H-daunomycin accumulation in drug-sensitive and drug-resistant human cancer cells. Moins N, Cayre A, Chevillard S, Maublant J, Verrelle P, Finat-Duclos F. Anticancer Res; 2000 Mar 09; 20(4):2617-23. PubMed ID: 10953334 [Abstract] [Full Text] [Related]
14. Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil. Julia AM, Roché H, Berlion M, Lucas C, Milano G, Robert J, Bizzari JP, Canal P. Br J Cancer; 1994 May 09; 69(5):868-74. PubMed ID: 8180016 [Abstract] [Full Text] [Related]
15. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance. Léonce S, Pierré A, Anstett M, Pérez V, Genton A, Bizzari JP, Atassi G. Biochem Pharmacol; 1992 Nov 03; 44(9):1707-15. PubMed ID: 1360210 [Abstract] [Full Text] [Related]
16. Comparative evaluation of S9788, verapamil, and cyclosporine A in K562 human leukemia cell lines and in P-glycoprotein-expressing samples from patients with hematologic malignancies. Merlin JL, Guerci A, Marchal S, Missoum N, Ramacci C, Humbert JC, Tsuruo T, Guerci O. Blood; 1994 Jul 01; 84(1):262-9. PubMed ID: 7912556 [Abstract] [Full Text] [Related]
17. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol. Arora A, Seth K, Kalra N, Shukla Y. Toxicol Appl Pharmacol; 2005 Feb 01; 202(3):237-43. PubMed ID: 15667829 [Abstract] [Full Text] [Related]
18. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells. Limtrakul P, Siwanon S, Yodkeeree S, Duangrat C. Phytomedicine; 2007 Jun 01; 14(6):381-9. PubMed ID: 17467965 [Abstract] [Full Text] [Related]
19. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents. Ihnat MA, Lariviere JP, Warren AJ, La Ronde N, Blaxall JR, Pierre KM, Turpie BW, Hamilton JW. Clin Cancer Res; 1997 Aug 01; 3(8):1339-46. PubMed ID: 9815817 [Abstract] [Full Text] [Related]
20. [Effect of S9788, cyclosporin A and verapamil on intracellular accumulation of doxorubicin, daunorubicin and daunorubicinol in primary rat hepatocyte culture]. Le Bot MA, Kernaleguen D, Simon I, Berlion M, Riché C. Ann Biol Clin (Paris); 1996 Aug 01; 54(1):21-4. PubMed ID: 8731791 [Abstract] [Full Text] [Related] Page: [Next] [New Search]